Atrys Health SA operates within the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Atrys Health SA with three other
pharmaceutical manufacturers in Europe:
sales of 7.08 million Euro [US$7.85 million]
of which 81%
was Research & Development Tax Credit),
Biotec Pharmacon ASA
(66.77 million Norwegian Kroner [US$7.44 million]
of which 51%
was Enzymes), and
Biomed Lublin Wytwornia Surowic I Szczepionek SA
based in Poland
(32.29 million Polish New Zlotys [US$8.45 million]
of which 100%
was Traditional Segment).